Translational research: A phase I study of niraparib and pimitespib in patients with solid tumor
Not Applicable
Recruiting
- Conditions
- unresectable recurrent solid tumor
- Registration Number
- JPRN-jRCT1030220300
- Lead Sponsor
- aito Yoichi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
1) Willing to participate in the A phase I study of niraparib and pimitespib in patients with solid tumor (jRCT2031220179).
2) Written consent has been obtained from the patient for this ancillary study.
3) Age 18 years or older on the date consent is obtained.
Exclusion Criteria
1) Patients who are regarded as inappropriate for enrollment by investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method